Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee considers allowing nasal‑spray epinephrine and broader delegation in school stock supplies
Summary
Legislative counsel described a compromise on H 209 to let Vermont schools keep non‑injectable epinephrine formulations in stock, broaden the statutory term to “epinephrine,” and clarify which school employees may be authorized to administer it under a provider standing order.
Senate Education Committee members on May 12 reviewed compromise language for H 209 that would allow schools to maintain a stock supply of epinephrine delivered by any FDA‑approved single‑use system, including recently approved intranasal formulations, rather than limiting the statute to auto‑injectors.
Katie McLennan, Office of Legislative Council, told the committee the bill’s main change replaces repeated references to “epinephrine auto‑injectors” with a definition that covers any FDA‑approved single‑use delivery system and spells out who may administer a school’s stock supply. “A designated personnel means a school employee, agent, or volunteer who has completed training required by the state board policy and who has been authorized by…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
